Immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 with 12-dose vials: An interim analysis

BACKGROUND: ChAdOx1 nCoV-19 (AZD 1222) is the main vaccine planned for general administration in Thailand. This vaccine is stored in multiple-dose vials meant to be administered to 10 recipients with a volume of 0.5 mL for each dose. However, the vaccine vials were overfilled, which allows the admin...

Descripción completa

Detalles Bibliográficos
Autores principales: Manomaipiboon, Anan, Phumisantiphong, Uraporn, Maneerit, Jakravoot, Chalearmchai, Yupin, Jirawathin, Warissara, Prajongsai, Achiraya, Phankavong, Patchara, Trakarnvanich, Thananda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692062/
https://www.ncbi.nlm.nih.gov/pubmed/34969542
http://dx.doi.org/10.1016/j.vaccine.2021.12.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692062/
https://www.ncbi.nlm.nih.gov/pubmed/34969542
http://dx.doi.org/10.1016/j.vaccine.2021.12.023

Ejemplares similares